Andreas Goutopoulos

CEO ActiThera

Seminars

Tuesday 11th November 2025
Towards Optimising Tumour Retention of FAP-Targeting Theranostics
2:10 pm
  • Discussing the promise of FAP as a target for the imaging and therapy of various solid tumours
  • Summarising approaches used in the FAP field to optimise tumour AUC
  • Exploring insights into Actithera’s approaches and molecules
Andreas Goutopoulos, CEO, ActiThera